Literature DB >> 17914131

A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects.

Juan A Paniagua1, Angel Gallego de la Sacristana, Esther Sánchez, Inmaculada Romero, Antonio Vidal-Puig, Francisco J Berral, Antonio Escribano, Maria José Moyano, Pablo Peréz-Martinez, José López-Miranda, Francisco Pérez-Jiménez.   

Abstract

OBJECTIVE: To study the effects of three weight-maintenance diets with different macronutrient composition on carbohydrate, lipid metabolism, insulin and incretin levels in insulin-resistant subjects.
METHODS: A prospective study was performed in eleven (7 W, 4 M) offspring of obese and type 2 diabetes patients. Subjects had a BMI > 25 Kg/m2, waist circumference (men/women) > 102/88, HBA1c < 6.5% and were regarded as insulin-resistant after an OGTT (Matsuda ISIm <4). They were randomly divided into three groups and underwent three dietary periods each of 28 days in a crossover design: a) diet high in saturated fat (SAT), b) diet rich in monounsaturated fat (MUFA; Mediterranean diet) and c) diet rich in carbohydrate (CHO).
RESULTS: Body weight and resting energy expenditure did not changed during the three dietary periods. Fasting serum glucose concentrations fell during MUFA-rich and CHO-rich diets compared with high-SAT diets (5.02 +/- 0.1, 5.03 +/- 0.1, 5.50 +/- 0.2 mmol/L, respectively. Anova < 0.05). The MUFA-rich diet improved insulin sensitivity, as indicated by lower homeostasis model analysis-insulin resistance (HOMA-ir), compared with CHO-rich and high-SAT diets (2.32 +/- 0.3, 2.52 +/- 0.4, 2.72 +/- 0.4, respectively, Anova < 0.01). After a MUFA-rich and high-SAT breakfasts (443 kcal) the postprandial integrated area under curve (AUC) of glucose and insulin were lowered compared with isocaloric CHO-rich breakfast (7.8 +/- 1.3, 5.84 +/- 1.2, 11.9 +/- 2.7 mmol . 180 min/L, Anova < 0.05; and 1004 +/- 147, 1253 +/- 140, 2667 +/- 329 pmol . 180 min/L, Anova <0.01, respectively); while the integrated glucagon-like peptide-1 response increased with MUFA and SAT breakfasts compared with isocaloric CHO-rich meals (4.22 +/- 0.7, 4.34 +/- 1.1, 1.85 +/- 1.1, respectively, Anova < 0.05). Fasting and postprandial HDL cholesterol concentrations rose with MUFA-rich diets, and the AUCs of triacylglycerol fell with the CHO-rich diet. Similarly fasting proinsulin (PI) concentration fell, while stimulated ratio PI/I was not changed by MUFA-rich diet.
CONCLUSIONS: Weight maintenance with a MUFA-rich diet improves HOMA-ir and fasting proinsulin levels in insulin-resistant subjects. Ingestion of a virgin olive oil-based breakfast decreased postprandial glucose and insulin concentrations, and increased HDL-C and GLP-1 concentrations as compared with CHO-rich diet.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17914131     DOI: 10.1080/07315724.2007.10719633

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  47 in total

Review 1.  The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon.

Authors:  Zora Djuric
Journal:  Nutr Rev       Date:  2011-12       Impact factor: 7.110

2.  The effect of almonds on inflammation and oxidative stress in Chinese patients with type 2 diabetes mellitus: a randomized crossover controlled feeding trial.

Authors:  Jen-Fang Liu; Yen-Hua Liu; Chiao-Ming Chen; Wen-Hsin Chang; C-Y Oliver Chen
Journal:  Eur J Nutr       Date:  2012-06-22       Impact factor: 5.614

3.  The insulin resistance phenotype (muscle or liver) interacts with the type of diet to determine changes in disposition index after 2 years of intervention: the CORDIOPREV-DIAB randomised clinical trial.

Authors:  Ruth Blanco-Rojo; Juan F Alcala-Diaz; Suzan Wopereis; Pablo Perez-Martinez; Gracia M Quintana-Navarro; Carmen Marin; Jose M Ordovas; Ben van Ommen; Francisco Perez-Jimenez; Javier Delgado-Lista; Jose Lopez-Miranda
Journal:  Diabetologia       Date:  2015-10-16       Impact factor: 10.122

Review 4.  Abdominal obesity and type 2 diabetes in Asian Indians: dietary strategies including edible oils, cooking practices and sugar intake.

Authors:  S Gulati; A Misra
Journal:  Eur J Clin Nutr       Date:  2017-06-14       Impact factor: 4.016

5.  Health benefits and evaluation of healthcare cost savings if oils rich in monounsaturated fatty acids were substituted for conventional dietary oils in the United States.

Authors:  Mohammad M H Abdullah; Stephanie Jew; Peter J H Jones
Journal:  Nutr Rev       Date:  2017-02-01       Impact factor: 7.110

6.  Role of fatty acid transport protein 4 in oleic acid-induced glucagon-like peptide-1 secretion from murine intestinal L cells.

Authors:  M A Poreba; C X Dong; S K Li; A Stahl; J H Miner; P L Brubaker
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-08-07       Impact factor: 4.310

7.  Palm olein and olive oil cause a higher increase in postprandial lipemia compared with lard but had no effect on plasma glucose, insulin and adipocytokines.

Authors:  Kim-Tiu Teng; Gowri Nagapan; Hwee Ming Cheng; Kalanithi Nesaretnam
Journal:  Lipids       Date:  2011-01-01       Impact factor: 1.880

Review 8.  Olive oil consumption and non-alcoholic fatty liver disease.

Authors:  Nimer Assy; Faris Nassar; Gattas Nasser; Maria Grosovski
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

9.  Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study.

Authors:  M A Martínez-González; C de la Fuente-Arrillaga; J M Nunez-Cordoba; F J Basterra-Gortari; J J Beunza; Z Vazquez; S Benito; A Tortosa; M Bes-Rastrollo
Journal:  BMJ       Date:  2008-05-29

10.  Effects of a plant-based high-carbohydrate/high-fiber diet versus high-monounsaturated fat/low-carbohydrate diet on postprandial lipids in type 2 diabetic patients.

Authors:  Claudia De Natale; Giovanni Annuzzi; Lutgarda Bozzetto; Raffaella Mazzarella; Giuseppina Costabile; Ornella Ciano; Gabriele Riccardi; Angela A Rivellese
Journal:  Diabetes Care       Date:  2009-09-09       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.